Standard Biotools (LAB) Assets Average (2011 - 2026)

Standard Biotools (LAB) has 16 years of Assets Average data on file, last reported at $603.4 million in Q1 2026.

• On a quarterly basis, Assets Average rose 1.25% year-over-year to $603.4 million in Q1 2026; TTM through Mar 2026 was $603.4 million, a 1.25% increase from a year earlier, with the FY2025 full-year figure at $590.0 million, up 26.16% from the prior year.
• Assets Average for Q1 2026 stood at $603.4 million, up from $553.7 million in the prior quarter.
• Over the last five years, Assets Average for LAB reached as high as $743.2 million in Q2 2024 and fell as low as $273.6 million in Q1 2022.
• Historically, Assets Average has averaged $493.5 million across 5 years, with a median of $548.3 million in 2025.
• Across the five-year window, Assets Average soared 104.32% in 2024 and declined 23.54% in 2025, its largest moves.
• Year by year, Assets Average stood at $402.6 million in 2022, then slipped by 17.74% to $331.2 million in 2023, then surged by 95.35% to $646.9 million in 2024, then retreated by 14.41% to $553.7 million in 2025, then rose by 8.98% to $603.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $603.4 million in Q1 2026, $553.7 million in Q4 2025, and $548.3 million in Q3 2025.